Johnson & Johnson said on Tuesday it would suspend the supply of its personal care products in Russia, joining a host of other companies that have distanced themselves from Russia in response to its invasion of Ukraine.
The drugmaker said it would continue to supply medicines and medical devices in the region. J&J’s consumer health segment sells a range of products for personal use including skin health, beauty and oral care products such as Neutrogena, Aveeno and Listerine.
Consumer goods giants such as PepsiCo Inc, Procter & Gamble Co and Nestle SA have said they will retain a presence in Russia to provide basic items for nutrition and hygiene, such as milk and diapers. AbbVie, which owns blockbuster wrinkle treatment Botox, said earlier this month it had temporarily suspended operations for all its aesthetics products in Russia.
J&J, along with several other drugmakers such as Eli Lilly and Co and Pfizer, has said it would stop enrollment in clinical trials in Russia. J&J has also said it was stopping enrollments as well as new site openings in Ukraine and Belarus, but was committed to providing essential health products.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)